圣湘生物: 圣湘生物科技股份有限公司关于董事会换届选举的公告

Board Restructuring Announcement - The second board of directors of Shengxiang Biotechnology Co., Ltd. is about to expire, and the company has initiated the election process for the third board of directors [1][2] - The company held a temporary meeting on July 10, 2025, to approve the nomination of candidates for the third board of directors, including both non-independent and independent directors [1][2] Candidate Nomination - The board of directors has nominated six candidates for non-independent directors and four candidates for independent directors, with Wang Shanping being a professional accountant [2] - The independent directors' qualifications must be approved by the Shanghai Stock Exchange before being submitted for shareholder approval [2] Current Board Members - Two independent directors, Cao Ya and Qiao Youlin, will not continue their roles due to the expiration of their six-year term [3] - The current board will continue to perform its duties until the new board is approved at the upcoming shareholder meeting [3] Candidate Qualifications - All nominated candidates meet the legal and regulatory requirements for board membership and have not faced any administrative penalties or disqualifications [2][12] - The candidates possess relevant educational backgrounds and work experiences that qualify them for their respective roles [2][12] Candidate Profiles - Detailed resumes of the nominated candidates highlight their qualifications, including educational achievements and professional experiences [5][7][9][11][14][18][20] - Notable candidates include Dai Lizhong, the current chairman and general manager, and Wang Shanping, an accounting professor with extensive experience in finance [5][12][18][20]